期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

艾司洛尔在胸外科术中快速房颤的应用

下载PDF
导出
摘要 目的探讨艾司洛尔在胸外科手术中快速房颤时的应用疗效。方法回顾分析本院2年来1480例胸外科手术患者术中的麻醉记录结果,分析房颤发生的时间、快速房颤的处理及结果等。结果出现慢性房颤(心室率<100次/min)3例,可不予处理;出现快速房颤(心室率>100次/min)8例,经静脉给予艾司洛尔心室率均满意降低。结论胸外科手术中发生的快速房颤使用艾司洛尔控制心室率是快速有效,安全可靠的。
作者 段红 谭晓红 陈一丁
机构地区 四川省肿瘤医院麻醉科
出处 《四川医学》 CAS 2007年第10期1150-1151,共2页 Sichuan Medical Journal
关键词 艾司洛尔 胸外手术 房颤
分类号 R614 [医药卫生—麻醉学]
  • 相关文献

参考文献6

  • 1孙艺红,胡大一.心房颤动治疗策略——是否转复窦性心律[J].中国医药导刊,2003,5(4):262-264. 被引量：11
  • 2Levy S,Breithardt G,Campbell WF,et al.On behalf of the working Group on Arrhythmial of the European Society of Cardiology.Atrial Fibrillation;Current Knowledge and recommendation for management[J].Eur heart J,1998,19(9):1294-1320
  • 3Prystowsky EN,Benson JD,Woodrow MD,et al.Management of patients with atrial fibrillatlon:a statement for healthcare professionals from subconmmittee on eletrocardiogrophy and eletrophysiology[J].American Heart Association Circulation,1996,93(6):1262-1277
  • 4Kuhlkamp V,Bosch R,Mewis C,et al.Use of bota-bloc Kers in atrial fibrillation[J].Am J Cardiovasc Drugs,2002,2(1):37-42
  • 5Demircam C,Cikriklar HI,Engindeniz I,et al.Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation[J].Emerg Med J,2005,22(6):411-414
  • 6李家泰.临床药理学[M]第2版[M].北京:人民卫生出版社,1998.914-9211199.

二级参考文献8

  • 1Wolf PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: The Frammingham study. Stroke,1991; 22:983.
  • 2ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J ,2001, 22:1852 - 1932.
  • 3AFFIRM investigators. Atrial fibrillation follow - up investigation of rhythm management - the AFFIRM study Design. Am J Cardiol,1997;79: 1198- 1202.
  • 4Wyse DG, AFFIRM Investigaters. Survival in patients presenting with atrial fibrillation: the atrial fibrillation follow - up investigation of rhythm management (AFFIRM) study. Program and Abstracts of the American College of Cardiology 51st Annual meeting; March 17- 20,2002;Atlanta,Georgia.Abstract 405 - 411.
  • 5Basta M, Gardner M J, Anderson DR, et al. Readmissions of patients hospitalized with atrial fibrillation: antiarrhythmia agents versus rate limiting drug therapy. Program and Abstracts of the North American Society of Pacing and Electrophisiology 23rd Annual Scientific Sessions; May 8- 11,2002;san Diego, California. Abstract 101743.
  • 6Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological intervention in Atrial Fibrillation (PIAF) : a randomized trial, Lancet, 2000;356: 1789- 1794.
  • 7Louise S. Jenkins, RN, PhD. Late Breaking Clinical Trials: AFFIRM (Atrial Fibrillation Follow - up Investigation of Rhythm Management)Functional Status and Quality of Life Substudy. Program and Abstracts of the North American Society of Pacing and Electrophisiology 23rd Annual Scientific Sessions; May 8- 11,2002;san Diego, California. Abstract.
  • 8Michele Brignole, MD. Rate Control: How to Do It and Is it Enough?Program and Abstracts of the North American Society of Pacing and Electrophisiology 23rd Annual Scientific Sessions; May 8- 11, 2002;san Diego, California. Abstract.

共引文献36

四川医学
2007年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部